(Q50145794)

25 February 2018

title

HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge. (English)

1 reference

25 February 2018

1 reference

3

1 reference

25 February 2018

Klaus Korn

Klaus Korn

10

0 references

Martin Stürmer

Martin Stürmer

14

0 references

Claudia Kücherer

11

Claudia Kücherer

1 reference

25 February 2018

Rolf Kaiser

8

Rolf Kaiser

1 reference

25 February 2018

Hauke Walter

17

Hauke Walter

1 reference

25 February 2018

Martin Däumer

5

Martin Däumer

1 reference

25 February 2018

author name string

Martin Obermeier

1

1 reference

25 February 2018

Alejandro Pironti

2

1 reference

25 February 2018

Patrick Braun

4

1 reference

25 February 2018

Josef Eberle

6

1 reference

25 February 2018

Robert Ehret

7

1 reference

25 February 2018

Niels Kleinkauf

9

1 reference

25 February 2018

Harm Müller

12

1 reference

25 February 2018

Christian Noah

13

1 reference

25 February 2018

Alexander Thielen

15

1 reference

25 February 2018

Eva Wolf

16

1 reference

25 February 2018

publication date

24 January 2012

1 reference

25 February 2018

published in

Intervirology

1 reference

25 February 2018

volume

55

1 reference

25 February 2018

issue

2

1 reference

25 February 2018

page(s)

102-107

1 reference

25 February 2018

Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.

cites work

1 reference

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score.

21 January 2018

1 reference

Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase

21 January 2018

1 reference

Tenofovir resistance and resensitization

21 January 2018

1 reference

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

21 January 2018

1 reference

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

21 January 2018

1 reference

Algorithms for the interpretation of HIV-1 genotypic drug resistance information

21 January 2018

1 reference

Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes

21 January 2018

1 reference

Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation

21 January 2018

1 reference

A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen

21 January 2018

1 reference

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

21 January 2018

1 reference

Evolutionary pathways of transmitted drug-resistant HIV-1.

21 January 2018

1 reference

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

21 January 2018

1 reference

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

21 January 2018

1 reference

Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy

21 January 2018

1 reference

Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).

21 January 2018

1 reference

Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?

21 January 2018

1 reference

Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.

21 January 2018

1 reference

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000331999

1 reference

25 February 2018

1 reference

25 February 2018